Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity.
about
In situ and in vivo study of nasal absorption of paeonol in rats.Is nose-to-brain transport of drugs in man a reality?Can formulation and drug delivery reduce attrition during drug discovery and development-review of feasibility, benefits and challenges.Delivery of ziconotide to cerebrospinal fluid via intranasal pathway for the treatment of chronic pain.Can nasal drug delivery bypass the blood-brain barrier?: questioning the direct transport theory.From prediction error to psychosis: ketamine as a pharmacological model of delusions.Targeted brain delivery of 17 beta-estradiol via nasally administered water soluble prodrugs.Drug delivery strategies for Alzheimer's disease treatment.Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery.Pharmacokinetic and pharmacodynamic response after intranasal administration of diazepam to rabbits.Newer drug delivery systems in anesthesia.Nasal delivery. The use of animal models to predict performance in man.Micellar nanocarriers: potential nose-to-brain delivery of zolmitriptan as novel migraine therapy.1-Methyl-1,2,3,4-tetrahydroisoquinoline antagonizes a rise in brain dopamine metabolism, glutamate release in frontal cortex and locomotor hyperactivity produced by MK-801 but not the disruptions of prepulse inhibition, and impairment of working memHydroxocobalamin uptake into the cerebrospinal fluid after nasal and intravenous delivery in rats and humans.Localization and differential activity of P-glycoprotein in the bovine olfactory and nasal respiratory mucosae.Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: the relation to the molecular weight of drugs.Nose-to-brain delivery of TS-002, prostaglandin D2 analogue.Dabigatran ameliorates post-haemorrhagic hydrocephalus development after germinal matrix haemorrhage in neonatal rat pups.Nasal route for direct delivery of solutes to the central nervous system: fact or fiction?MK-801 increases locomotor activity without elevating extracellular dopamine levels in the nucleus accumbens.The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra.Transnasal delivery of 5-fluorouracil to the brain in the rat.
P2860
Q35002223-0D433255-CE9F-4E2E-A331-85E2319437D9Q35673938-37AA44D4-2FDC-4599-81CB-69290AD77622Q36111924-489DE056-3833-45D4-AB57-C5368DBBFD54Q36563732-497DD15D-A278-4C05-A70F-C116EA09F1BDQ36807954-359641F7-F25A-4DB1-BFF9-6A42EC9B5A01Q36860032-F7FE84E5-E91E-4456-893B-24659FC9C5CCQ37360504-073FDE6F-859A-4EAD-A317-5D3BF0A6F322Q37851509-AE0AB793-E601-4859-83CC-2680B3836064Q38741041-46EFF1FA-4BAC-4C80-8ECD-F0FF5F7130C8Q40647017-852B00F8-90BB-4BF5-97EA-97F79FFB13BEQ41081606-530E5618-F8EE-4297-A824-F5E19FE6EDC4Q41156918-662B33A5-09CC-436C-B899-E505008054D9Q41619376-2CB3E5A6-4128-4777-91DC-6F871D8969B7Q43299739-EEBAFB01-3173-4BF4-9D1B-6B818EA339EDQ44688158-A8AFAAB0-B1E8-42E8-8219-2C65035A5D27Q46607428-FF14572D-1084-4598-8B6F-1A50DB337A3CQ47355443-CF474662-6D51-4A6D-88ED-60F4AC6F1CC5Q48238626-B8CA9151-767F-4AB8-9541-B866B4E4012FQ48326580-1C535DBE-3F41-414D-84B4-2EAB546FEC6DQ48369715-FBC95354-90A7-4823-AC2A-72BC54BAAE27Q48906983-145A412C-C227-4801-A2F7-170A6DF09A5EQ49028706-2A0FF6CC-258A-4FDE-9DC9-DBD6E728D812Q52081891-2B1737E2-D214-45D0-BE50-78DB0A8D65E1
P2860
Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity.
@en
Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity.
@nl
type
label
Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity.
@en
Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity.
@nl
prefLabel
Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity.
@en
Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity.
@nl
P2093
P2860
P1476
Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity.
@en
P2093
Yamashita S
P2860
P304
P356
10.1111/J.2042-7158.1991.TB03510.X
P577
1991-06-01T00:00:00Z